This Week in Cell

In Cell this week, researchers in Italy say that TAZ, a transducer of the Hippo pathway, is responsible for conferring the properties of cancer stem cells onto breast cancer cells. TAZ is required to sustain self-renewal and tumor-initiation capacities in breast cancer stem cells, the authors write. "TAZ protein levels and activity are elevated in prospective CSCs and in poorly differentiated human tumors and have prognostic value," they add.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Researchers find that a personalized medicine approach could help people who experience pain while taking statins, New Scientist reports.

US National Science Foundation is continuing its responsible research conduct training policy despite its flaws, ScienceInsider reports.

A CRISPR-themed meeting explored how the tool could and should be used, Wired reports.

In Science this week: database of proteins' effects on cancer, targeted error correction sequencing, and more.